Home
Network
Vision and Mission
Steering Committee
Members
Meetings
Join us
Training
Advocate
Establish
Strengthen
Evaluate
Media Center
News
SYSVAC
About
Registry
E-learning course
Events
Sign in
*
*
Home
Media Center
Media Center
Type of publications
NITAG documentation
Scientific publications
Regions
Africa
Americas
Europe
Countries
Argentina
Belgium
Canada
France
Kenya
United Kingdom
United States of America
Diseases
Dengue
Diphtheria
Ebola
Haemophilus influenzae type B
Hepatitis A
Hepatitis B
Herpes zoster
Human papillomavirus
(-)
Influenza
Japanese encephalitis
Measles
Meningitis
Mumps
Pertussis
Pneumococcal disease
Poliomyelitis
Rabies
Rotavirus
Rubella
Tetanus
Tuberculosis
Typhoid
Varicella
Yellow fever
Publication date
(-)
2018
(-)
2005
2020
2019
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
Developing a seasonal influenza vaccine recommendation in Kenya: Process and challenges faced by the National Immunization Technical Advisory Group (NITAG)
evidence-based recommendations
Download:
EN
Published: 2018
Author: Jeanette Dawa, Sandra Chaves, Antoinette Ba-Nguz, Rosalia Kalani, Edwina Anyango
CoNaIn meeting minutes - December 2018
Agenda & Minutes
Download:
ES
Published: 2018
Author: CoNaIn
October 2018 - meeting minutes
anthrax
adult vaccination
adolescents
Agenda & Minutes
Download:
EN
Published: 2018
Author: ACIP
June 2018 - meeting minutes
anthrax
supply shortage
Agenda & Minutes
Download:
EN
Published: 2018
Author: ACIP
February 2018 - meeting minutes
anthrax
evidence-based recommendations
Agenda & Minutes
Download:
EN
Published: 2018
Author: ACIP
Minutes of the CTV meeting - December 18th 2018
supply shortage
meeting minutes
Agenda & Minutes
Download:
FR
Published: 2018
Author: Haute Autorité de Santé
Agenda of the CTV meeting - July 17th 2018
Agenda & Minutes
Download:
FR
Published: 2018
Author: Haute Autorité de Santé
Agenda of the CTV meeting - June 5th 2018
Agenda & Minutes
Download:
FR
Published: 2018
Author: Haute Autorité de Santé
Literature Review Update on the Efficacy and Effectiveness of High-Dose (Fluzone® High-Dose) and MF59-Adjuvanted (Fluad®) Trivalent Inactivated Influenza Vaccines in Adults 65 Years of Age and Older
Background paper
Download:
EN
FR
Published: 2018
Author: NACI
Literature Review on Individuals with Neurologic or Neurodevelopment Conditions and Risk of Serious Influenza-Related Complications
Background paper
Download:
EN
FR
Published: 2018
Author: NACI
Home
Network
Training
Media Center
News
SYSVAC
Events
Sign in / Register